Pro-angiogenic microRNA-296 upregulates vascular endothelial growth factor and downregulates Notch1 following cerebral ischemic injury

Molecular Medicine Reports

Volumn 12, Issue 6, 2015, Pages 8141-8147

  Feng, Jie ^a   Huang, Tianxiang ^a   Huang, Qing ^a   Chen, Hua ^a   Li, Yu ^a   He, Wei ^a   Wang, Gui Bin ^a   Zhang, Le ^a   Xia, Jian ^a   Zhang, Ning ^a   Liu, Yunhai ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Angiogenesis; Cerebral ischemia; MicroRNA; MicroRNA 296; Notch; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 296; NOTCH1 RECEPTOR; SCATTER FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ESCRT PROTEIN; HEPATOCYTE GROWTH FACTOR-REGULATED TYROSINE KINASE SUBSTRATE; MIRN296 MICRORNA, RAT; NOTCH1 PROTEIN, RAT; PHOSPHOPROTEIN; VASCULOTROPIN A;

ADENOVIRIDAE; AGED; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CAPILLARY DENSITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; ANIMAL; BRAIN; BRAIN ARTERY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CEREBRAL ARTERIES; DOWN-REGULATION; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NOTCH1; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84946761097     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.4436     Document Type: Article

References (30)

1. Wang Y, Liao X, Zhao X, et al: Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: Analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke 42: 1658-1664, 2011.
2. Jauch EC, Saver JL, Adams HP Jr, et al: Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44: 870-947, 2013.
3. Zhang C: MicroRNomics: A newly emerging approach for disease biology. Physiol Genomics 33: 139-147, 2008.
4. Zhang T, Weilang X, Liu Y, et al: MicroRNAs and stroke: A brief summary of recent research progress. J Mol Diagn Ther 4: 1-10, 2010.
5. Wang S, Aurora AB, Johnson BA, et al: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
6. Fasanaro P, D'Alessandra Y, Di Stefano V, et al: MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883, 2008.
7. Bonauer A, Carmona G, Iwasaki M, et al: MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324: 1710-1713, 2009.
8. Würdinger T, Tannous BA, Saydam O, et al: miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14: 382-393, 2008.
9. Goldmacher GV, Nasser R, Lee DY, et al: Tracking transplanted bone marrow stem cells and their effects in the rat MCAO stroke model. PLoS One 8: e60049, 2013.
10. Lobov IB, Renard RA, Papadopoulos N, et al: Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104: 3219-3124, 2007.
11. Bederson JB, Pitts LH, Germano SM, et al: Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304-1308, 1986.
12. Fonsatti E, Altomonte M, Nicotra MR, et al: Endoglin (CD105): A powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 22: 6557-6563, 2003.
13. Lloyd-Jones D, Adams RJ, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121: e46-e215, 2010.
14. Scheinowitz M: Therapeutic myocardial angiogenesis: Past, present and future. Mol Cell Biochem 264: 75-83, 2004.
15. Krupi-ski J, Ka-uza J, Kumar P, Kumar S and Wang JM: Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798, 1994.
16. Marti HJ, Bernaudin M, Bellail A, et al: Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156: 965-976, 2000.
17. Hamada Y, Gonda K, Takeda M, et al: In vivo imaging of the molecular distribution of the VEGF receptor during angiogenesis in a mouse model of ischemia. Blood 118: e93-e100, 2011.
18. Hedhli N, Dobrucki LW, Kalinowski A, et al: Endothelial-derived neuregulin is an important mediator of ischaemia-induced angiogenesis and arteriogenesis. Cardiovasc Res 93: 516-524, 2012.
19. Krupi-ski J, Kaluza J, Kumar P, et al: Some remarks on the growth-rate and angiogenesis of microvessels in ischemic stroke. Morphometric and immunocytochemical studies. Patol Pol 44: 203-209, 1993.
20. Sun Y, Jin K, Xie L, et al: VEGF-induced neuroprotection, neurogenesis and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843-1851, 2003.
21. Harrigan MR, Ennis SR, Sullivan SE, et al: Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir (Wien) 145: 49-53, 2003.
22. Navaratna D, Guo S, Arai K and Lo EH: Mechanisms and targets for angiogenic therapy after stroke. Cell Adhes Migr 3: 216-223, 2009.
23. Thurston G, Rudge JS, Ioffe E, et al: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463, 2000.
24. Gertz K, Priller J, Kronenberg G, et al: Physical activity improves long-term stroke outcome via endothelial nitric oxide synthase-dependent augmentation of neovascularization and cerebral blood flow. Circ Res 99: 1132-1140, 2006.
25. Ghosh G, Subramanian IV, Adhikari N, et al: Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-isoforms and promotes angiogenesis. J Clin Invest 120: 4141-4154, 2010.
26. Lou Y-L, Guo F, Liu F, et al: miR-210 activates notch signaling pathway in angiogenesis induced by cerebral ischemia, Mol Cell Biochem 370: 45-51, 2012.
27. Ewan LC, Jopling HM, Jia H, et al: Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic 7: 1270-1282, 2006.
28. Carmeliet P, De Smet F, Loges S and Mazzone M: Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way. Nat Rev Clin Oncol 6: 315-326, 2009.
29. Gerhardt H, Golding M, Fruttiger M, et al: VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161: 1163-1177, 2003.
30. Siekmann AF and Lawson ND: Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 445: 781-784, 2007.